Sverre Lehmann

Sverre Lehmann is an active Associate Professor (MD, PhD) at the University of Bergen's Faculty of Medicine and Dentistry, specifically affiliated with Clinical Department 2 and the Pulmonary Department at Haukeland University Hospital in Bergen, Norway. His clinical and research work focuses on respiratory medicine with particular emphasis on obstructive lung diseases and sleep-related breathing disorders.

Dr. Lehmann's primary research interests include obstructive lung disease (asthma and COPD), sleep-related respiratory disorders, and respiratory failure. His work spans clinical epidemiology, pathophysiology, and treatment outcomes in these areas. He has made significant contributions to understanding the relationship between sleep apnea severity and inflammatory markers, oral appliance therapy effectiveness, and the microbiome in chronic respiratory diseases.

His recent publication record demonstrates substantial research activity, with numerous articles published in 2023-2025 focusing on obstructive sleep apnea treatment optimization, severe asthma management with biologics, and lung microbiome research in COPD and pulmonary fibrosis. His work shows a clear trend toward interdisciplinary research connecting respiratory medicine, sleep disorders, and inflammatory mechanisms.

Dr. Lehmann maintains active collaborations with researchers at the University of Bergen, Haukeland University Hospital, and international partners, particularly through the International Severe Asthma Registry. His research often involves cross-disciplinary teams including pulmonologists, sleep specialists, dentists, and epidemiologists.

He completed his doctoral thesis titled 'Adrenergic bronchodilator test in community. Applicability and relationship to anthropometrical variables, smoking, respiratory symptoms, and lung function' in 2008, establishing his expertise in respiratory function testing that continues to inform his current research.